Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Austin, TX
SEC filing record 1 source field available
Fiscal year end
31 December
FILANA THERAPEUTICS, INC. has filed 1,212 SEC EDGAR filings since 14 Mar 2000

SEC filing history

Showing 651-675 of 785 matching filings.

Per page
25
Current page
27
8-K File 000-29959

FORM 8-K FILING DOCUMENT

Filing date
09 Feb 2012
Reporting date
09 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59335

SCHEDULE 13G AMENDMENT NO. 7

Filing date
06 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Dec 2011
Reporting date
16 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Dec 2011
Reporting date
16 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Dec 2011
Reporting date
16 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-29959

FORM 8-K

Filing date
22 Dec 2011
Reporting date
20 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Nov 2011
Reporting date
01 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Nov 2011
Reporting date
01 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-29959

FORM 8-K FILING DOCUMENT

Filing date
03 Nov 2011
Reporting date
03 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Oct 2011
Reporting date
18 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Oct 2011
Reporting date
03 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Sep 2011
Reporting date
15 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Sep 2011
Reporting date
16 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Sep 2011
Reporting date
16 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Sep 2011
Reporting date
16 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Aug 2011
Reporting date
08 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Aug 2011
Reporting date
08 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-29959

FORM 8-K/A

Filing date
04 Aug 2011
Reporting date
04 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-29959

FORM 8-K FILING DOCUMENT

Filing date
04 Aug 2011
Reporting date
04 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
20 Jul 2011
Reporting date
15 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59335

SCHEDULE 13G AMENDMENT - PAIN THERAPEUTICS

Filing date
19 Jul 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .